Results 1 - 10 of 19
Results 1 - 10 of 19. Search took: 0.02 seconds
|Sort by: date | relevance|
[en] A plant life management (PLiM) programme is an effective tool that allows an operator to manage ageing effects in structures, systems and components (SSCs) for long term operation of nuclear power plants. Such a programme helps facilitate decisions concerning when and how to repair, replace or modify SSCs in an economically optimized way, while assuring that the highest levels of safety are maintained. This publication is the proceedings of the fourth in a series of international conferences convened by the IAEA on nuclear power plant life management. The conference provided a forum for information exchange on national and international policies, as well as on regulatory practices, and for the demonstration of strategies, including their application in ageing management and PLiM programmes for operating and new nuclear power plants. The proceedings include the opening address, presentations of the keynote speakers, summaries of the individual technical sessions, and conclusions and recommendations of the chairperson of the conference.
[en] We would like to confirm our commitment to support our Member States in improving nutrition in these difficult times. Have a look at the suggestions for conducting IAEA nutrition studies during the COVID-19 pandemic. Mainly working from home, we continued with our activities in the second half of 2020 and conducted meetings and training workshops in a virtual format. We have discussed progress of research projects, identified new research agendas, strengthened expertise in deuterium-based isotope techniques and established new collaborations with nutrition societies. We contributed to the Micronutrient Forum 5th Global Conference CONNECTED 2020 and to the 11th Africa Day for Food and Nutrition Security. Check out new publications presenting results from different IAEA-supported projects.
[en] The main objectives of this meeting/workshop are to: Discuss the development of the draft GIF report provisionally entitled Safety Design Guidelines on Key Structures, Systems and Components; Discuss the review comments of external stakeholders on GIF report on Safety Design Guidelines on Key Structures, Systems and Components; Discuss the development of the Safety Design Criteria and Safety Design Guidelines for lead and lead-bismuth cooled fast reactors; and Share information on the implementation of SDG for SFRs and SDC for LFRs by the designers of the innovative LMFR concepts.
[en] We started off a new Coordinated Research Project (CRP) on data evaluation of Fission Yields, which aims to produce high quality evaluated data for many actinide targets including the major actinides at different neutron incident energies. There were 51 participants in the meeting, which shows a rather large interest in this very specialized field. Detailed nuclear reaction evaluation methodology and ongoing evaluations were discussed in the yearly INDEN meetings on actinides and structural materials. In addition, we hosted meetings on neutron standards and nuclear data for the back end of the fuel cycle. Our Atomic and Molecular Data Unit held two virtual Research Coordination Meetings for their Coordinated Research Projects on atomic data for fusion design. Artificial Intelligence and Machine Learning are now rapidly invading all branches of science, and nuclear data is no exception to that. In this Newsletter you will find a short summary on a Consultancy Meeting we held recently. As always, all presentations can be found on our website.
[en] National nuclear institutes (NNIs) contribute significantly to national development, providing services focused on developing and applying relevant technologies for the public good. While many NNIs provide commercial services and products that generate revenue, some are financially dependent on subsidies from national governments. This publication presents the outcome of a workshop which addressed the challenges for Member States regarding self-reliance and sustainability of their NNIs. Participants discussed efforts and best practices to cope with these challenges. The publication includes positive examples of tools or measures to be used in practical projects and programmes for achieving management goals towards self-reliance and sustainability. Examples of governmental policies in support of self-reliance and sustainability of NNIs are also presented. Finally, the country presentations in this publication show some examples of how NNIs cooperate with public or private stakeholders, providing some insights on how partnership opportunities can be explored.
[en] This publication was developed from the exchange of information, experiences and practices by participating Member States at the IAEA Technical Meeting on the Safety and Security Interface — Approaches and National Experiences, held in Vienna in 2018. It aims to provide a better understanding of the important elements of the interface between nuclear safety and nuclear security for facilities and activities and to highlight the challenges, opportunities and good practices for its effective management when planning and implementing different programmes and activities.
[en] Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) is used for (re)staging prostate cancer (PCa) and as a biomarker for evaluating response to therapy, but lacks established response criteria. A panel of PCa experts in nuclear medicine, radiology, and/or urology met on February 21, 2020, in Amsterdam, The Netherlands, to formulate criteria for PSMA PET/CT-based response in patients treated for metastatic PCa and optimal timing to use it. Panelists received thematic topics and relevant literature prior to the meeting. Statements on how to interpret response and progression on therapy in PCa with PSMA PET/CT and when to use it were developed. Panelists voted anonymously on a nine-point scale, ranging from strongly disagree (1) to strongly agree (9). Median scores described agreement and consensus. PSMA PET/CT consensus statements concerned utility, best timing for performing, criteria for evaluation of response, patients who could benefit, and handling of radiolabeled PSMA PET tracers. Consensus was reached on all statements. PSMA PET/CT can be used before and after any local and systemic treatment in patients with metastatic disease to evaluate response to treatment. Ideally, PSMA PET/CT imaging criteria should categorize patients as responders, patients with stable disease, partial response, and complete response, or as non-responders. Specific clinical scenarios such as oligometastatic or polymetastatic disease deserve special consideration. Adoption of PSMA PET/CT should be supported by indication for appropriate use and precise criteria for interpretation. PSMA PET/CT criteria should categorize patients as responders or non-responders. Specific clinical scenarios deserve special consideration.
[en] Clinically qualified medical physicists are physicists working in healthcare who have received adequate academic postgraduate education in medical physics and relevant supervised clinical training. They work as members of multidisciplinary teams that provide services to patients in radiotherapy, nuclear medicine, and diagnostic and interventional radiology. Clinically qualified medical physicists also work in other areas where ionizing or non-ionizing radiation or physics principles are used for diagnosis and treatment of patients. Imaging and therapeutic processes, procedures and interventions are dependent on the safe and effective use of information, science and technologies, and thus require qualified professionals to ensure optimal and appropriate patient care through quality assurance and optimization. The knowledge and competencies of medical physicists are acquired through academic education and clinical training programmes that fulfil internationally defined criteria. International professional organizations recognize the need for continuing education and professional development and promote the certification of medical physicists to ensure a high standard of patient care. In 2013, the IAEA published Roles and Responsibilities, and Education and Training Requirements for Clinically Qualified Medical Physicists (IAEA Human Health Series No. 25). The publication, endorsed by the International Organization for Medical Physics and the American Association of Physicists in Medicine, highlights the need for certification and registration of medical physicists as well as continuing professional development, and provides specific guidance on the establishment of a certification scheme. Only a limited number of countries currently have national medical physics certification schemes. The International Medical Physics Certification Board was formed in 2010, with the main objective of supporting the practice of medical physics through a certification programme in accordance with the International Organization for Medical Physics guidelines. Consultations with medical physics organizations and certification bodies have revealed a lack of international guidance in this area. To address this gap, in 2018 the IAEA convened a consultants’ meeting to prepare a publication highlighting the need for and benefits of medical physics certification, and providing information on the establishment of national or regional certification schemes. This publication builds on the experience and lessons learned from professional organizations and certification bodies and provides information on certification pathways in different scenarios. It is addressed to medical physics professionals and residents; medical practitioners in radiotherapy, nuclear medicine, and diagnostic and interventional radiology; health authorities and hospital administrators; and radiation protection regulatory agencies. This publication has been endorsed by the International Medical Physics Certification Board and the International Organization for Medical Physics.
[en] This publication summarizes the results of an IAEA technical meeting to review and discuss the analysis, simulation, and modelling of severe accident progression in spent fuel pools. The emphasis was on achieving a better understanding of drivers for improvement to address risks associated with accidents in spent fuel pools, progression to failure of the spent fuel, and the subsequent release of fission products. Discussion sessions enabled the exchange of information regarding the analysis of severe accidents in spent fuel pools, the provision of an overview of current research and development (R&D) activities, and considerations for the planning and execution of further R&D. The meeting served as a forum for Member States to exchange knowledge on current and new code development and methodologies, to identify the gaps for future improvements, and gather information for collaboration on all these aspects.